Found 10 matching trials
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma PHASE2 This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Fostamatinib for Hospitalized Adults With COVID-19 PHASE2 Background:
COVID-19 is a new disease caused by SARS-CoV-2 that was identi...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC. PHASE1 A Phase 1b/2, open-label, randomized study to evaluate MEDI-573 in combinat...
Show More Learn More & Join Trial
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis PHASE1 This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Show More Location
Precision NextGen Oncology
Learn More & Join Trial
Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control PHASE2 This study aims to assess the survival benefit from an early switch approac...
Show More Location
Medizinische Universität Wien - Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onkologie
Learn More & Join Trial
Masitinib in Patients With Mild Alzheimer's Disease PHASE3 Masitinib is an orally administered tyrosine kinase inhibitor that targets ...
Show More Location
Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière
Learn More & Join Trial
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies PHASE1 This clinical trial is a Phase 1-2, open-label, sequential-group, dose-esca...
Show More Location
University of Southern California
Learn More & Join Trial
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy PHASE1 Phase I: evaluate the safety and tolerability two different dosing regimens...
Show More Location
Azienda Sanitaria Locale Frosinone
Learn More & Join Trial
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer PHASE2 Participants will have been diagnosed with advanced progressive thyroid can...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC PHASE2 This research study is studying a type of radiation therapy called Stereota...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial